On the correction factors for small field dosimetry in 1.5T MR-linacs.

Phys Med Biol

Medical Physics Laboratory, School of Medicine, National and Kapodistrian University of Athens, 75 Mikras Asias, Goudi, Athens, Attica, 11527, GREECE.

Published: January 2025

Clinical dosimetry in the presence of a 1.5T magnetic field is challenging, let alone in case small fields are involved. The scope of this study is to determine a set of relevant correction factors for a variety of MR-compatible detectors with emphasis on small fields. Two dosimetry formalisms adopted from the literature are considered. Approach: Six small-cavity ionization chambers (from three manufacturers), four active solid-state detectors and a TLD microcube were modeled in the EGSnrc Monte Carlo (MI) code. Phase space files for field sizes down to 1×1 cm2 of the Unity 1.5T/7MV MR-linac (Elekta, UK) were used as source models. Simulations were performed to calculate the kQ,QBf,fB (also known as kB,Q), kQmsrB, fmsr and kQclin,QmsrB,fclin,fmsr relevant to two different dosimetry formalisms. Two detector orientations with respect to the magnetic field were considered. Moreover, the effect of the ionization chamber's stem length (a construction parameter) on the correction factor was investigated. Simulations were also carried out to determine whether correction factors obtained in water can be applied in dosimetry procedures involving water-equivalent solid phantoms. Main results: Under the kQ,QBf,fB-based formalism, the required corrections to ionization chamber responses did not exceed 1.5% even for the smallest field size considered. A much wider range of kQ,QBf,fB values was obtained for the active solid-state detectors included in the simulations. This is the first study to report kQclin,QmsrB,fclin,fmsr values for ionization chambers. The impact of the stem on correction factors is not significant for lengths ≥0.75cm. Correction factors determined in water are also valid in dosimetry protocols employing solid phantoms. Significance: This work substantially expands the range of available detectors that can be used in small field dosimetry, enabling more options for commissioning, beam modeling and QA procedures in 1.5T MR-Linacs. However, more studies are needed to establish a complete and reliable dataset. .

Download full-text PDF

Source
http://dx.doi.org/10.1088/1361-6560/ada682DOI Listing

Publication Analysis

Top Keywords

correction factors
20
small field
8
field dosimetry
8
15t mr-linacs
8
magnetic field
8
small fields
8
dosimetry formalisms
8
ionization chambers
8
active solid-state
8
solid-state detectors
8

Similar Publications

Plasma brain-related biomarkers and potential therapeutic targets in pediatric ECMO.

Neurotherapeutics

January 2025

Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address:

Extracorporeal membrane oxygenation (ECMO) is a technique used to support severe cardiopulmonary failure. Its potential life-saving benefits are tempered by the significant risk for acute brain injury (ABI), from both primary pathophysiologic factors and ECMO-related complications through central nervous system cellular injury, blood-brain barrier dysfunction (BBB), systemic inflammation and neuroinflammation, and coagulopathy. Plasma biomarkers are an emerging tool used to stratify risk for and diagnose ABI, and prognosticate neurofunctional outcomes.

View Article and Find Full Text PDF

Objective: To identify the risk factors for proximal junctional failure (PJF) after adult spinal deformity (ASD) surgery despite ideal sagittal correction according to age-adjusted alignment target.

Methods: The study included patients who underwent low thoracic to pelvic fusion for ASD and obtained ideal correction according to age-adjusted pelvic incidence minus lumbar lordosis. PJF was defined either radiographically as a proximal junctional angle (PJA) of >28° plus a difference in PJA of >22° or clinically as revision surgery for proximal junctional complications.

View Article and Find Full Text PDF

Objectives: Factors affecting denosumab-induced hypocalcemia in male patients with osteoporosis remain unclear because of the small patient population. Nevertheless, it is important to explore male-specific risk factors. This study aimed to identify the factors affecting the development of denosumab-induced hypocalcemia in male patients with osteoporosis and compare them with those in female patients with osteoporosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!